An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth.
Lam H, McNeil LK, Starobinets H, DeVault VL, Cohen RB, Twardowski P, Johnson ML, Gillison ML, Stein MN, Vaishampayan UN, DeCillis AP, Foti JJ, Vemulapalli V, Tjon E, Ferber K, DeOliveira DB, Broom W, Agnihotri P, Jaffee EM, Wong KK, Drake CG, Carroll PM, Davis TA, Flechtner JB.
Lam H, et al. Among authors: gillison ml.
Cancer Discov. 2021 Mar;11(3):696-713. doi: 10.1158/2159-8290.CD-20-0377. Epub 2021 Jan 27.
Cancer Discov. 2021.
PMID: 33504579